More cases of rare blood clots, but regulator says benefits still outweigh risk
The number of cases of rare blood clots among the millions of people in the UK who have had the Oxford/AstraZeneca vaccine has risen to 168.
Full Article
More cases of rare blood clots, but regulator says benefits still outweigh risk
Belfast Telegraph
0 shares
1 views
You might like
Related news coverage
The Latest: Washington state resumes J&J inoculations
SeattlePI.com
OLYMPIA, Wash. — Gov. Jay Inslee said Saturday that inoculations with the Johnson & Johnson vaccine can begin in Washington state..
-
As U.S. Leans On Vaccines To Contain Spread, COVID-19 Surges Elsewhere
Newsy
-
CDC says women under 50 are at the highest risk of blood clots after J&J shot as advisors debate the vaccine's future
Business Insider
-
EU agency says people should get 2nd dose of AstraZeneca too
SeattlePI.com
-
EU agency to issue more guidance on AstraZeneca's COVID shot
SeattlePI.com
Advertisement
More coverage
J&J vaccine 'pause' latest messaging challenge for officials
SeattlePI.com
NEW YORK (AP) — Confronted with rare cases of blood clots potentially linked to Johnson & Johnson’s COVID-19 vaccine, U.S...
-
Johnson & Johnson to Resume European Union Vaccine Rollout
NYTimes.com
-
J. & J. to Resume E.U. Vaccine Rollout, With Warning of Rare Side Effect
NYTimes.com
-
J.&J.’s vaccine should carry warning of potential risk for rare blood clots, the E.U.’s regulator says, but believes benefits outweigh risks.
NYTimes.com
-
EU regulator finds link between Johnson & Johnson shot and blood clots
Denver Post